Yilong Wang
Clinical trials sponsored by Yilong Wang, explained in plain language.
-
New drug ALT001 tested for rare brain disorder
Disease control Not yet recruitingThis early-phase study tests a new drug, ALT001, in 60 adults aged 30-75 with multiple system atrophy (MSA), a rare brain disease that affects movement and automatic body functions. The main goal is to check if the drug is safe and to see if it might help control symptoms. Partic…
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Skull bone injection could boost meningitis treatment
Disease control Not yet recruitingThis study tests a new method of giving antibiotics for moderate-to-severe bacterial meningitis. Instead of only giving antibiotics through a vein, doctors will also inject them into the skull bone to help more medicine reach the brain. The trial will include 86 adults who have n…
Phase: NA • Sponsor: yilong Wang • Aim: Disease control
Last updated May 04, 2026 16:23 UTC